J2919
J2919 – Inj, methylpred sod succ 5mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 35 NDCs crosswalked per 5 MG $0.224/unit ASP+6%
📋 J2919 summary
J2919 is a HCPCS Level II J-code used to bill methylpred sod succ 5mg, billed per 5 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2919: Methylprednisolone Sodium Succ*, Solu-Medrol, Methylprednisolone Sodium Succinate
Code J2919
Billing unit 5 MG Payment limit $0.224/unit NDC-Crosswalk 35
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2919
DescriptorInj, methylpred sod succ 5mg
Billing unit5 MG
Payment limit / unit$0.224
Est. ASP / unit$0.211 est.
Mapped NDCs35
Data periodQ3 2026
Last updated2026-08-20
💊 About Methylprednisolone Injection DRUG GUIDE
Methylprednisolone acetate injectable suspension is used when oral treatment isn't practical and covers a broad range of conditions.
Given by intramuscular injection, it treats severe allergic conditions (such as asthma flares, drug reactions, and serum sickness), skin diseases, endocrine disorders, blood disorders, gastrointestinal diseases, and inflammatory conditions of the eyes, lungs, kidneys, and nervous system.
It is also used for palliative management of leukemias and lymphomas, and for rheumatic disorders including rheumatoid arthritis, lupus, dermatomyositis, and polymyositis.Given by intra-articular (into a joint) or soft tissue injection, it provides short-term relief for conditions like acute gouty arthritis, bursitis, and rheumatoid arthritis.
Given by intralesional (directly into a skin lesion) injection, it treats conditions such as alopecia areata (hair loss), keloids, psoriatic plaques, and discoid lupus erythematosus.
Clinical overview from our editorial drug guide for Methylprednisolone Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.224
Est. ASP / unit
$0.211 est.
Est. after 2% sequester
$0.220
HCPCS dosage
5 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2919 = 5 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2919 LEAST EXPENSIVE FIRST
35 NDCs map to J2919. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.224/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9754-25 | Methylprednisolone Sodium Succinate 125 mg/1 INJECTION, POWDER, FOR SOLUTION | Hikma | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-975... | 125 mg/1 | 625 | $140.00 | $3.585 | ● Active | CMS + PDAC |
| 43598-0129-25 | Methylprednisolone sodium succinate 125 mg/2mL INJECTION | Dr. | 25 VIAL, SINGLE-DOSE in 1 CARTON (43598-12... | 125 mg/2mL | 625 | $140.00 | $3.585 | ● Active | CMS + PDAC |
| 63323-0258-03 | Methylprednisolone Sodium Succinate 125 mg/2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-258-... | 125 mg/2mL | 625 | $140.00 | $3.585 | Obsolete | CMS ASP |
| 00009-0039-06 | SOLU-MEDROL methylprednisolone sodium succinate 40 mg/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0039-06) / 1 mL... | 40 mg/mL | 200 | $44.80 | $6.281 | ● Active | CMS + PDAC |
| 00009-0039-28 | SOLU-MEDROL methylprednisolone sodium succinate 40 mg/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0039-28) / 1 mL... | 40 mg/mL | 200 | $44.80 | $6.281 | ● Active | CMS ASP |
| 00009-0039-32 | SOLU-MEDROL methylprednisolone sodium succinate 40 mg/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0039-32) / 1 mL... | 40 mg/mL | 200 | $44.80 | $6.281 | ● Active | CMS ASP |
| 00009-0047-22 | SOLU-MEDROL methylprednisolone sodium succinate 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0047-22) / 2 mL... | 125 mg/2mL | 625 | $140.00 | $10.051 | ● Active | CMS ASP |
| 00009-0003-02 | SOLU-MEDROL methylprednisolone sodium succinate 500 mg/4mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0003-02) / 4 mL... | 500 mg/4mL | 100 | $22.40 | — | ● Active | CMS ASP |
| 00009-0018-20 | SOLU-MEDROL methylprednisolone sodium succinate 1 g/8mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0018-20) / 8 mL... | 1 g/8mL | 200 | $44.80 | — | ● Active | CMS ASP |
| 00009-0047-04 | SOLU-MEDROL methylprednisolone sodium succinate 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0047-04) / 2 mL... | 125 mg/2mL | 625 | $140.00 | — | ● Active | CMS + PDAC |
| 00009-0047-26 | SOLU-MEDROL methylprednisolone sodium succinate 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 25 VIAL in 1 CARTON (0009-0047-26) / 2 mL... | 125 mg/2mL | 625 | $140.00 | — | ● Active | CMS ASP |
| 00009-0698-01 | SOLU-MEDROL methylprednisolone sodium succinate 1 g/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0698-01) / 16 mL... | 1 g/mL | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 00009-0698-02 | SOLU-MEDROL methylprednisolone sodium succinate 1 g/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0698-02) / 16 mL... | 1 g/mL | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 00009-0758-01 | SOLU-MEDROL methylprednisolone sodium succinate 500 mg/mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0758-01) / 8 mL... | 500 mg/mL | 100 | $22.40 | — | ● Active | CMS + PDAC |
| 00009-0850-01 | SOLU-MEDROL methylprednisolone sodium succinate 2 g/30.6mL INJECTION, POWDER, FOR SOLUTION | Pharmacia | 1 VIAL in 1 CARTON (0009-0850-01) / 30.6... | 2 g/30.6mL | 400 | $89.60 | — | ● Active | CMS + PDAC |
| 00143-9753-25 | Methylprednisolone Sodium Succinate 40 mg/1 INJECTION, POWDER, FOR SOLUTION | Hikma | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-975... | 40 mg/1 | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 00143-9850-01 | Methylprednisolone Sodium Succinate 500 mg/1 INJECTION, POWDER, FOR SOLUTION | Hikma | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIA... | 500 mg/1 | 100 | $22.40 | — | ● Active | CMS + PDAC |
| 00143-9851-01 | Methylprednisolone Sodium Succinate 1 g/1 INJECTION, POWDER, FOR SOLUTION | Hikma | 1 INJECTION, POWDER, FOR SOLUTION in 1 VIA... | 1 g/1 | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 00404-9957-02 | Solu-Medrol Methylprednisolone Sodium Succinate 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | Henry | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9957-02... | 125 mg/2mL | 25 | $5.60 | — | ● Active | CMS ASP |
| 00404-9958-01 | Solu-Medrol Methylprednisolone Sodium Succinate 40 mg/mL INJECTION, POWDER, FOR SOLUTION | Henry | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9958-01... | 40 mg/mL | 8 | $1.79 | — | ● Active | CMS ASP |
| 43598-0127-25 | Methylprednisolone sodium succinate 40 mg/mL INJECTION | Dr. | 25 VIAL, SINGLE-DOSE in 1 CARTON (43598-12... | 40 mg/mL | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 43598-0128-11 | Methylprednisolone sodium succinate 500 mg/8mL INJECTION | Dr. | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-128-... | 500 mg/8mL | 100 | $22.40 | — | ● Active | CMS + PDAC |
| 43598-0130-74 | Methylprednisolone sodium succinate 1 g/16mL INJECTION | Dr. | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-130-... | 1 g/16mL | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 50090-0271-00 | SOLU-MEDROL methylprednisolone sodium succinate 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | A-S | 2 mL in 1 VIAL (50090-0271-0) | 125 mg/2mL | 25 | $5.60 | — | ● Active | CMS ASP |
| 50090-0271-01 | Solu-Medrol | A-S | — | — | 625 | $140.00 | — | — | CMS ASP |
| 51662-1263-01 | SOLU-MEDROL 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | HF | 1 mL in 1 VIAL, SINGLE-USE (51662-1263-1) | 125 mg/2mL | 25 | $5.60 | — | ● Active | CMS ASP |
| 51662-1263-03 | SOLU-MEDROL 125 mg/2mL INJECTION, POWDER, FOR SOLUTION | HF | 25 POUCH in 1 CASE (51662-1263-3) / 1 mL... | 125 mg/2mL | 625 | $140.00 | — | ● Active | CMS ASP |
| 51662-1264-01 | SOLU-MEDROL 40 mg/mL INJECTION, POWDER, FOR SOLUTION | HF | 1 mL in 1 VIAL, SINGLE-DOSE (51662-1264-1) | 40 mg/mL | 8 | $1.79 | — | ● Active | CMS ASP |
| 51662-1264-03 | SOLU-MEDROL 40 mg/mL INJECTION, POWDER, FOR SOLUTION | HF | 25 POUCH in 1 CASE (51662-1264-3) / 1 mL... | 40 mg/mL | 200 | $44.80 | — | ● Active | CMS ASP |
| 63323-0255-03 | Methylprednisolone Sodium Succinate 40 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-255-... | 40 mg/mL | 200 | $44.80 | — | Obsolete | CMS ASP |
| 63323-0265-30 | Methylprednisolone Sodium Succinate 1 g/16mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Fresenius | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-265-... | 1 g/16mL | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 72572-0097-25 | Methylprednisolone Sodium Succinate 40 mg/1 INJECTION, POWDER, FOR SOLUTION | Civica, | 25 VIAL, SINGLE-DOSE in 1 CARTON (72572-09... | 40 mg/1 | 200 | $44.80 | — | ● Active | CMS + PDAC |
| 72572-0098-25 | Methylprednisolone Sodium Succinate 125 mg/1 INJECTION, POWDER, FOR SOLUTION | Civica, | 25 VIAL, SINGLE-DOSE in 1 CARTON (72572-09... | 125 mg/1 | 625 | $140.00 | — | ● Active | CMS + PDAC |
| 70121-1000-05 | Methylprednisolone Sodium Succinate 40 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Amneal | 25 VIAL in 1 CARTON (70121-1000-5) / 1 mL... | 40 mg/mL | 8 | $1.79 | — | ● Active | PDAC |
| 70121-1001-05 | Methylprednisolone Sodium Succinate 125 mg/2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Amneal | 25 VIAL in 1 CARTON (70121-1001-5) / 2 mL... | 125 mg/2mL | 25 | $5.60 | — | ● Active | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$358.5K
Claims
61,362
Beneficiaries
41,366
Spend / beneficiary
$8.67
Spend / claim
$5.84
Trend by period
Where J2919 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #471 of 824
#466
ALLOPLY, PER SQ CM** Q4323
$387.1K
#467
DOCETAXEL J9171
$375.5K
#468
CARBOPLATIN* J9045
$364K
#469
EOVIST A9581
$362.8K
#470
OASIS BURN MATRIX** Q4103
$362.6K
#471
METHYLPREDNISOLONE S... J2919
$358.5K
#472
BICILLIN L-A J0561
$356.8K
#473
ORBACTIV J2407
$354.4K
#474
SUBLOCADE(Q9992) Q9992
$345.4K
#475
CYCLOPHOSPHAMIDE(J90... J9074
$344K
#476
IODIXANOL(Q9966)* Q9966
$341.3K
Total claims — #40 of 824
#35
ORENCIA CLICKJECT* J0129
70,350
#36
CELLCEPT* J7517
67,841
#37
DEPO-TESTOSTERONE* J1071
65,852
#38
GADAVIST* A9585
65,285
#39
PREDNISONE INTENSOL* J7512
65,179
#40
METHYLPREDNISOLONE S... J2919
61,362
#41
AFLURIA (3YR UP)* 90656
60,542
#42
EUFLEXXA J7323
60,496
#43
SODIUM CHLORIDE(J703... J7030
59,637
#44
MYCOPHENOLIC ACID* J7518
57,045
#45
IODIXANOL(Q9966)* Q9966
56,735
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $358.5K | 41,366 | 61,362 | $8.67 | $5.84 |
| 2025 (Q1-Q4) | $3.67M | 327,508 | 587,685 | $11.19 | $6.24 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$1.47M
Medicare paid
$1.08M
Submitted services
6,425,200
Denial rate
7.3%
Allowed / service
$0.25
Submitted charges
$17.28M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2919 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 2,389,093 services across 53 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J2919
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Not available in current dataset
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
35 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2919 billing FAQ
What is HCPCS code J2919?
J2919 is a HCPCS Level II J-code used to bill Inj, methylpred sod succ 5mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2919?
One unit of J2919 represents 5 MG. Report the number of units equal to the dose administered divided by 5 MG.
How many units of J2919 should I bill?
Divide the dose administered by the code's unit size (5 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2919?
The Medicare Part B payment limit is $0.224 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.220 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2919?
35 NDCs currently map to J2919 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2919 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.